Exchange: OTC·Updated 09:37 AM EDT

NYMXF Nymox Pharmaceutical Corp

$0.0002
$0.0001
(33.33%)
Today
Mkt Cap$18,908.00
Vol13,417.00

About NYMXF

Nymox Pharmaceutical Corp. engages in the research and development of products for the aging population. Its products include NicAlert, TobacAlert and Fexapotide Triflutate for the treatment of low-grade localized prostate cancer. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.
51

Neutral Sentiment

How do you feel about NYMXF?

Advertisement|Remove ads.